Metabolism of ipecac alkaloids cephaeline and emetine by human hepatic microsomal cytochrome P450s, and their inhibitory effects on P450 enzyme activities.
暂无分享,去创建一个
T. Yanagisawa | H. Kamei | C. Sadakane | T Asano | H Kushida | C Sadakane | K Ishihara | Y Wakui | T Yanagisawa | M Kimura | H Kamei | T Yoshida | Y. Wakui | T. Yoshida | T. Asano | M. Kimura | H. Kushida | K. Ishihara
[1] M. Ohba,et al. Quinolizidines. XII. Synthetic Incorporation of Ethyl Cincholoiponate into a Tricyclic Intermediate Adaptable to Chiral Syntheses of the 10-Hydroxy-9-methoxybenzo [a] quinolizidine-Type Alangium Alkaloids , 1985 .
[2] Y. Fujii,et al. Vomiting induction by ipecac syrup in dogs and ferrets. , 1997, The Journal of toxicological sciences.
[3] T. Tanahashi,et al. Ipecac alkaloids from Cephaelis acuminata. , 1999, Phytochemistry.
[4] M. Relling,et al. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. , 1990, The Journal of pharmacology and experimental therapeutics.
[5] M. P. Arlotto,et al. Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. , 1991, Methods in enzymology.
[6] D. Greenblatt,et al. In Vitro Prediction of the Terfenadine‐Ketoconazole Pharmacokinetic Interaction , 1994, Journal of clinical pharmacology.
[7] D. Back,et al. Theophylline metabolism in human liver microsomes: inhibition studies. , 1996, The Journal of pharmacology and experimental therapeutics.
[8] M. Ohba,et al. Quinolizidines. XVI. Chiral Syntheses of 9-Demethylcephaeline and 10-Demethylcephaeline , 1985 .
[9] T. Kronbach,et al. Mephenytoin hydroxylation polymorphism: Characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo , 1985, Clinical pharmacology and therapeutics.
[10] T. Igarashi,et al. Identification of human cytochrome P450 isoforms involved in the metabolism of brotizolam. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.
[11] B. Sproule,et al. Selective Serotonin Reuptake Inhibitors and CNS Drug Interactions , 1997, Clinical pharmacokinetics.
[12] Kiyoshi Inoue,et al. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes , 1999, Archives of Toxicology.
[13] M. Ohba,et al. Quinolizidines. XI. Structure determination of the Alangium alkaloid desmethylpsychotrine through synthetic incorporation of ethyl cincholoiponate into (+)-9-demethylpsychotrine , 1985 .
[14] C. C. Brackett,et al. Phenytoin as a Possible Cause of Acetaminophen Hepatotoxicity: Case Report and Review of the Literature , 2000, Pharmacotherapy.
[15] J S Harmatz,et al. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. , 1996, The Journal of pharmacology and experimental therapeutics.
[16] T. Kronbach,et al. High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. , 1987, Analytical biochemistry.
[17] J. P. Saetta,et al. Residual Gastric Content after Gastric Lavage and Ipecacuanha-Induced Emesis in Self-Poisoned Patients: An Endoscopic Study , 1991, Journal of the Royal Society of Medicine.